246 results about "Nitro reduction" patented technology

The invention concretely relates to a synthetic technology for pyraclostrobin. The synthetic technology comprises: firstly performing cyclization to obtain 1-(4-chlorophenyl)-pyrazol-3-one, oxidizing the pyrazol ring under the effect of an oxidant to generate 1-(4-chlorophenyl)-3-hydroxypyrazole, then using 2-nitrobenzyl bromide to performing etherification to generate 1-(4-chlorophenyl)-3-[2-(nitrophenyl)methoxy]-1H-pyrazole, then using a reducing agent to perform nitro reducing, so as to generate N-hydroxyl-2-[N'-(4-chlorophenyl)pyrazol-3'-yloxymethyl]aniline, then using ClCO2CH3 to perform N-acylation reaction to generate methyl N-hydroxyl-N-2-{[N'-(4-chlorophenyl)pyrazol-3'-yloxymethyl]phenyl}formate, and finally performing hydroxyl methylation under an alkaline condition to generate pyraclostrobin. The technology enables all operations in the pyraclostrobin preparation process to be relatively controllable, helps to improve the stability of the preparation process and improve the product yield, successfully employs low-cost reagents and substantially reduces production cost, and also the employed reagents are relatively small in toxicity, is relatively beneficial for environment protection, and has no corrosivity on plastic pipes, so that the production safety is improved.

The invention provides a method for preparing an anti-depression medicine vilazodone, which comprises the following steps of: performing nitro reduction on 5-nitrobenzofuran-2-ethyl carboxylate serving as a raw material, conjugating with chlorohydrin, chlorinating by using phosphorus trichloride, cyclizing with 4-aminobutyric acid to generate a piperazine ring, performing acylchlorination, condensing with halogenated indole, performing carbonyl reduction, cyaniding, performing amidation, and the like to obtain the vilazodone. The method overcomes the defects in the prior art, is suitable for industrial production and has high application value, the used raw material is readily available, operating cost is low, and reaction yield is high.

The invention discloses a preparation method of eliglustat serving as a medicament for an I type Gaucher disease. The preparation method comprises the following steps: carrying out Henry reaction on 2, 3-dihydro-1, 4-benzodioxane-6-aldehyde and 2-(pyrrolidine-1-yl)-1-nitroethane in the presence of a chiral catalyst, and then carrying out nitro reduction and amidation reaction on the product to prepare the eliglustat (I). The preparation method is easy in raw material acquisition and simple and concise in process, is economical and environmentally friendly and is suitable for industrial production. Meanwhile, the invention also discloses 2-(pyrrolidine-1-yl)-1-nitroethane (III) serving as a raw material for preparing the eliglustat and a preparation method of the eliglustat.

The invention discloses a preparation method of apixaban.The method comprises the steps that paranitroaniline serves as the raw material, paranitroaniline and delta-valerolactone are subjected to amidation ring-opening, substituting and ring-closing reactions under the action of AlMe3, and a compound 8 is obtained; the compound 8 is subjected to alpha-position dichloro substituting and condensation-elimination reactions, and a compound 7 is obtained; the compound 7 and a compound 6 are subjected to [3+2] cyclization-elimination and nitro reduction, and a compound 4 is obtained; the compound 4 sequentially reacts with delta-valerolactone and ammonium chloride under the action of AlMe3, and a compound 3 is obtained; the compound 3 is subjected to substituting and ring closing, and apixaban is obtained.According to the preparation method of apixaban, paranitroaniline and delta-valerolactone which are low in price are adopted to serve as the raw materials, operation of the whole route is simple, conditions of each reaction are mild, and the synthesizing method is easy to operate, high in yield and purity and suitable for industrial production.

The invention relates to a method for preparing an intermediate of axitinib and application of the intermediate in preparation of axitinib. The preparation method for the intermediate of axitinib 3-iodine-6-nitro-1-(teralin-2H-pyran-2-base)-1H-indazole comprises the following steps that 6-nitroindazole and 3,4-dihydro-2H-pyran react under the action of catalyst so as to protect perssad tetralin-2H-pyran-2-base at N-H site, and the key intermediate with high yield is obtained through iodination at site 3. The application of the intermediate in preparation of axitinib is as follows: Heck coupled reaction is carried out on the intermediate and 2-vinyl pyridine, then nitro reduction and diazo-reaction for iodination are sequentially carried out, finally, the axitinib is obtained after docking of 2-sulfydryl-N-methyl benzamide and deprotection. The related main initial raw materials are easy to purchase in markets, and the method has high yield and high molecule economic efficiency, is efficient and environment-friendly, and is suitable for industrial mass production.

The invention relates to a preparation method and applications of a hyperbranched azo polymer, belonging to the organic synthesis field. The preparation method comprises the steps: firstly, performing nitroreduction and carboxyl acylation by taking p-nitrobenzoic acid as a raw material, to obtain an A2 type monomer azo-bi(benzoyl chloride) with an azobenzene structure, and then reacting the A2 type monomer azo phthaloyl dichloride with a B3 type monomer glycerol according to certain mole ratio to obtain the hyperbranched azo polymer. The materials of the obtained hyperbranched azo polymer has higher thermo-optical coefficient which is more than ten times of that of inorganic materials such as borosilicate glass, zinc silicate glass, silica glass and the like, and the material provides a possibility for developing a novel digital thermo-optical switch with low driving power.

The invention provides a method for preparing candesartan cilexetil, which can solve the problems of longer reaction route, easy remaining of toxic substances in medicines and lower total yield existing in the prior art. In the method, the candesartan cilexetil is finally prepared by using 2-amino-3-nitrobenzoic acid as an initial raw material through esterification reaction, N-alkylation reaction, nitro reduction reaction, cyclization reaction, hydrolysis reaction, esterification reaction and tetrazole protecting group deprotection reaction. The synthetic method has simple steps and high yield, greatly reduces the participation and generation of toxic products in the reaction process, reduces the release of waste and is beneficial to clean production.

The invention discloses a preparation method of efinaconazole (I). The preparation method comprises the following steps: performing asymmetric addition reaction on 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazole-1-yl)aceton (II) and nitroethane in the presence of a catalyst cupreine and a promoter benzoic acid to generate (2R,3R)-3-nitro-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazole-1-yl)-2-butanol (III); performing nitro reduction reaction on the intermediate (III) to generate (2R,3R)-3-amino-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazole-1-yl)-2-butanol (IV); and performing cyclization reaction on the intermediate (IV) and 1,5-di-halogen-3-methylene pentane (V) to prepare efinaconazole (I). The preparation method is easily available in raw materials and concise in process, is economical and environment-friendly and is suitable for industrial production.

The invention discloses a synthetic method of mirabegron, which comprises the following steps: 1)amine-ester exchange reaction: taking (R)-mandelic ester and 4-nitrophenethylamine as raw materials for an ester interchange reaction to obtain a mirabegron intermediate A; 2)amide reduction: reducing amide of the mirabegron intermediate A to obtain a mirabegron intermediate B; C)nitro reduction: performing a reduction reaction of the mirabegron intermediate B and a reducing agent stannous chloride to obtain a mirabegron intermediate C; and D)condensation reaction: performing a condensation reaction of the mirabegron intermediate C and 2-aminothiazole-4-acetate under the effect of a condensing agent to obtain mirabegron. The synthetic method has the advantages of low cost of raw material and high yield of product, and is suitable for large scale industrial production.

The invention discloses a main chain type azobenzene polymer and a preparation method thereof. According to the preparation method, the main chain type aromatic azo polymer is prepared by adopting nitro reduction coupling reaction for the first time. The preparation method comprises the following steps: firstly synthesizing different types of monomers through a series of reactions, namely conjugate monomers and non-conjugate monomers; secondly, synthesizing a photocatalyst required by a polymerization system, namely gold nanoparticles loaded on zirconium oxide, and characterizing the photocatalyst through a series of tests; and finally carrying out nitro reduction coupling reaction of the monomers in the presence of a methylbenzene-isopropanol mixed solvent and potassium hydroxide, thus obtaining the main chain type aromatic azo polymer. The preparation method disclosed by the invention needs few polymerization reaction components, is simple, practicable, convenient in a purification process, mild in reaction conditions and has the advantages of low toxicity, high efficiency and environmental protection. The main chain type aromatic azo polymer prepared by using the method has good solubility and functionality and high optical application value.

The invention discloses a derivant of kutkin with chemical structural formula as formula I, wherein R1 is NO2, NH2 or amide; R2 is H, carbonyl or diaminocarbonyl. The preparing method comprises the following steps: nitrating kutkin to obtain kutkin derivant substituted by nitro group or kutkin derivant based on substituted nitro group; or kutkin derivant substituted by acetylamino.

The invention discloses an aromatic azoxybenzene compound and a preparation method thereof. The preparation method comprises the following steps: firstly reducing aromatic nitro-compounds into azoxybenzene through photoinduction in an alkaline condition; firstly synthesizing different aromatic nitro-compounds; secondly, carrying out nitro reduction under the irradiation of a xenon lamp under the conditions of potassium hydroxide, methylbenzene and isopropyl alcohol, and thus synthesizing the aromatic azoxybenzene compound. The preparation method disclosed by the invention has the advantages of simple components, mild reaction conditions, low toxicity, environmental protection, high selectivity and the like; the obtained aromatic azoxybenzene compound has potential application in the aspects of dyes, liquid crystal materials, optical materials and the like.

The invention discloses a synthesis method of diamine monomer containing carborane structure. The method includes: synthesis of carborane double lithium, synthesis of carborane dinitro compound and synthesis of carborane diamine monomer. The carborane double lithium reacts with 4-nitrobenzylbromide to produce the dinitro compound containing carborane, and a nitro reduction reaction is employed for generation of the diamine monomer containing carborane. The synthesis process for diamine monomer containing carborane structure is simple, has easily controllable reaction process and high yield, can be used as an important diamine for the synthesis of high temperature resistant polyimide, and has the potential application value in high temperature and neutron protection.

The invention discloses a preparation method of an erlotinib intermediate, i.e., 3-aminobenzeneacetylene. The method comprises the following steps of: performing a Vilsmeier reaction on 3-nitrobenzene ethyl ketone (I) serving as an industrial raw material to obtain an intermediate, i.e., 1-chloro-1-(3-nitrobenzophenone)-2-(N,N-dimethyl formaldehyde oxime)-yl-ethylene (II) containing a halogen-substituted alkene bond; performing a dehydration reaction to obtain a formyl intermediate, i.e., 1-chloro-1-(3-nitrobenzophenone)-2-formaldehyde)-yl-ethylene (III); performing an elimination reaction to obtain an intermediate, i.e., 3-nitrophenylacetylene (IV); and performing a nitro reduction reaction on the intermediate, i.e., 3-nitrophenylacetylene (IV) to obtain the erlotinib intermediate, i.e., 3-aminobenzeneacetylene (intermediate A). The preparation method can contribute to improving the atom economy, process simplicity and environment friendliness, so that the the erlotinib intermediate, i.e., 3-aminobenzeneacetylene can be prepared easily and conveniently.

The invention relates to a method for preparing an expectorant, namely ambroxol key intermediate trans-4-[(2-amino benzyl) amino]-cyclohexanol. Nitrobenzaldehyde and trans-4-amino cyclohexanol are subjected to the combination reaction of condensation, carbon and nitrogen double-bond hydrogenation and nitro reduction to prepare the trans-4-[(2-amino benzyl) amino]-cyclohexanol in a high-yield mode. The method has the advantages of reasonable process route design, simple and convenient process, high reaction yield, low raw material cost and no harsh reaction conditions and is easy for scale production.

The invention discloses a preparation method of 5-chloro-2-methoxy cyanophenyl, relating to the technical field of medicine intermediates. The method is characterized by using fluoronitrobenzene as an initial raw material, and conducting bromination, nitro reduction, diazotization-Sandmeyer, Williamson substitution and carbonitriding to synthesize 5-chloro-2-methoxy cyanophenyl. The 5-chloro-2-methoxy cyanophenyl obtained by the method is a white powdery solid with the purity of 99.5%, the feed stock conversion each step respectively reaches 100%, and the total yield of the whole process reaches 48%.

The invention provides a preparation method of a tedizolid phosphate intermediate compound 3-fluoro-4-(6-(2-methyltetrazole-5-yl)pyridine-3-yl)phenyl benzyl carbamate. The method comprises the following steps: carrying out a reaction on 5-bromo-2-(2-methyltetrazole-5-yl)pyridine as a raw material and triisopropyl borate under the action of n-butyllithium to prepare a boric acid intermediate, coupling the boric acid intermediate and 1,2-difluoro-4-nitrobenzene, and finally performing nitro reduction and amidation to obtain the required target product. Compared with the method in the prior art,the preparation method disclosed by the invention has the advantages of easily available raw materials, simple process, economy, environmental protection and suitability for industrial production.

The invention discloses a method for preparing 4-amino-N-[(2R,3S)-3-amino-2-hydroxy-4-benzene butyl]-N-isobutyl benzsulfamide. The method comprises the following steps: S1: enabling L-phenylalanine and diazomethane to react to obtain a diazo methyl ketone intermediate product, and enabling the diazo methyl ketone intermediate product and haloid acid to react to obtain a compound A; S2, conducting carbonyl deoxidation on the compound A to obtain a compound B; S3, under the existence of iso-butylamine, conducting cyclization reaction and ring-opening reaction on the compound B in sequence to obtain a compound C; S4, enabling the compound C and nitrobenzenesulfonyl chloride to react to obtain a compound D; S5, conducting nitro reduction on the compound D to obtain the 4-amino-N-[(2R,3S)-3-amino-2-hydroxy-4-benzene butyl]-N-isobutyl benzsulfamide. The method is simple in course, low in cost, mild in condition, and higher in intermediate product stability, and is beneficial for industrial application.

The invention discloses a method for synthesizing S-3-(piperidine-2-yl)-azacyclo-azetidine-3-alcohol. The method comprises the following steps: condensing a compound S-N-Boc-piperidine-2-formic acid of a formula A and CDI so as to obtain a compound of a formula B; condensing the compound of the formula B and nitromethane under an alkali condition so as to obtain a compound C; enabling the compound C and a halogen methyl Grignard reagent to react so as to obtain a compound D; performing nitro reduction and cyclization on the compound D so as to obtain a compound I; condensing a compound of a formula I and a compound of a formula II in the alkali environment so as to obtain a compound of a formula III; performing deprotection on the compound of the formula III under an acid condition, thereby obtaining the S-3-(piperidine-2-yl)-azacyclo-azetidine-3-alcohol. The method disclosed by the invention is cheap and easily obtainable in raw material, simple and convenient in process operation, small in waste pollution, green and economic and easy in industrialization; by adopting the method disclosed by the invention, use of a conventional chiral resolution method is avoided, and a feasible technical scheme is provided for large-scale production of Cobimetinib.

The invention discloses a method for ultrasound-assisted synthesis of N-arylsulfonamide. N-arylsulfonamide compound is synthesized by series reaction of nitro reduction/sulfonyl chloride reduction/sulfonamidation with taking aromatic nitro compounds, sulfonyl chloride and iron powder as raw materials under ultrasonic stirring conditions. Water is used as a reaction medium and a hydrogen source inthe reaction. The method has the advantages of cheap and easily obtained raw materials, simple and mild reaction conditions, environmental friendliness, saving energy, high reaction selectivity and high yield, excellent compatibility of substrate functional groups and high application value.